Cameroon vs Myanmar: Treatment coverage for lymphatic filariasis
Cameroon
33.8%
in 2021
Myanmar
23.8%
in 2024
Cameroon rank
46th
Myanmar rank
48th
Treatment coverage for lymphatic filariasis over time
- Cameroon
- Myanmar
How they compare
Cameroon currently reports 33.8% against 23.8% in Myanmar, a difference of 10.0%.
That makes Cameroon's figure about 1.4 times Myanmar's.
The two have swapped places 5 times across 13 shared years of data; in 2008 it was Myanmar ahead.
Cameroon ranks 46th and Myanmar ranks 48th of 66 countries.
Myanmar has averaged higher in every one of the 3 decades both report.
Head to head by decade
| Decade | Cameroon | Myanmar | Difference | Ahead |
|---|---|---|---|---|
| 2000s | 8.1% | 33.3% | 25.1% | Myanmar |
| 2010s | 52.5% | 56.8% | 4.3% | Myanmar |
| 2020s | 16.9% | 46.9% | 30.0% | Myanmar |
Averages of every year both report within each decade.
Frequently asked questions
- Which has higher treatment coverage for lymphatic filariasis, Cameroon or Myanmar?
- Cameroon, at 33.8% against 23.8% in Myanmar as of 2021.
- What is the difference in treatment coverage for lymphatic filariasis between Cameroon and Myanmar?
- 10.0%, with Cameroon ahead.
- How many years of comparable data are there for Cameroon and Myanmar?
- 13 years are reported by both, from 2008 to 2021.
- How do Cameroon and Myanmar rank globally for treatment coverage for lymphatic filariasis?
- Cameroon ranks 46th and Myanmar ranks 48th of 66 countries.
- Where does this data come from?
- World Health Organization (2025) – with minor processing by Our World in Data, published as Treatment coverage for lymphatic filariasis. Statizoid refreshes it automatically from the source and publishes the full history for both places.
Individual pages
About this data
Drug coverage out of estimated population who require it.